FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2739459975> ?p ?o ?g. }

• W2739459975 abstract "B11 Breast cancer is the most common malignancy and accounts for 33% of all incident cancers in women in North America. Approximately one-third of women with breast cancer develop metastases and ultimately die from the disease. The current and future cancer treatment is mostly based on research on breast cancer cell lines so that their detailed molecular analysis may yield a better diagnostic test. There are several kinds of cell lines representing breast cancer. These cell lines have some common characteristics showing their breast cancer origin, like expressing milk proteins, but the cell lines show some discrepancies as well.
 Integrins are a large family of heterodimeric proteins that mediate cell-cell and cell-extra cellular matrix adhesion. αvβ3 is one of the integrins that is not expressed in high levels in normal tissues but in some cancer cells its higher expression is correlated directly to tumorogenecity. Although the expression of αvβ3 integrin and other related proteins have been studied in different cell lines, but there is not enough information on the effect/s of PMA on the expression of αvβ3 and different signaling proteins in breast cancer cell lines.
 In this paper three different kinds of breast cancer cell (BCC) lines; MDA-435, MDA-231, and MCF7 were treated with PMA. Beside these cell lines a non-breast cancer cell line (Hek-293) was studied along other cell lines for any possible differences. The time course PMA-treatment included, 30m, 1h, 2h, 4h and 6h. Western blot analysis and flow cytometry techniques were used to compare the level of αv, β3, αvβ3, Erk, phospho Erk, Src, phospho Src, Fak and phospho Fak proteins in these cells before and after PMA treatment.
 Flow cytometry and Western blot analysis revealed that all the cell lines express αv subunit, but only MDA-435 expressed αvβ3 integrin. PMA treatment increases αv level in MDA-435, while in other cell lines don’t change significantly. Western blot analysis demonstrated that MDA-231 expressed the highest level of FAK, which increases after a 1-2 hour exposure to PMA. The highest level of c-Src protein was detected in MDA-435 cells and the lowest in MCF7. PMA treatment increases c-Src level in MDA-435, and decreases in Hek-293. All the cell lines expressed detectable levels of Erk1/2, the level of which, did not change with PMA treatment. No phospho Erk was detected in untreated cells while PMA treatment resulted in a differential pattern of phospho Erk expression. PMA treatment induced Erk phosphorylation in MDA-435 and MCF7 after a 30 to 120 minutes, a gradual increase over six hours in MDA-231 cells, and at all times in Hek-293s.All the cell lines show the same level of Mek1/2 before or after PMA treatment, but only MDA-435 and MDA-231 show activation of phospho-Mek before PMA treatment. PMA treatment, resulted in phospho-Mek activation in MDA435 and Hek-293 after 30m to 4 h, after 30m to 2h in MDA-231, and barely detectable levels were detected in MCF7. Our results show that different cancer cell lines respond differently to PMA. These differences are more prominent in MAPK pathway (phospho Erk and phospho Mek). As MAP kinase pathway is one of the potential biomarker in cancer prevention, these findings may have applications in genetic epidemiology and prevention of breast cancer." @default.
• W2739459975 created "2017-07-31" @default.
• W2739459975 creator A5035796664 @default.
• W2739459975 creator A5066998785 @default.
• W2739459975 date "2007-10-01" @default.
• W2739459975 modified "2023-09-26" @default.
• W2739459975 title "Different response of breast cancer cell lines to PMA treatment" @default.
• W2739459975 hasPublicationYear "2007" @default.
• W2739459975 type Work @default.
• W2739459975 sameAs 2739459975 @default.
• W2739459975 citedByCount "0" @default.
• W2739459975 crossrefType "journal-article" @default.
• W2739459975 hasAuthorship W2739459975A5035796664 @default.
• W2739459975 hasAuthorship W2739459975A5066998785 @default.
• W2739459975 hasConcept C121608353 @default.
• W2739459975 hasConcept C126322002 @default.
• W2739459975 hasConcept C143998085 @default.
• W2739459975 hasConcept C1491633281 @default.
• W2739459975 hasConcept C195687474 @default.
• W2739459975 hasConcept C203014093 @default.
• W2739459975 hasConcept C502942594 @default.
• W2739459975 hasConcept C530470458 @default.
• W2739459975 hasConcept C54355233 @default.
• W2739459975 hasConcept C71924100 @default.
• W2739459975 hasConcept C81885089 @default.
• W2739459975 hasConcept C85789140 @default.
• W2739459975 hasConcept C86803240 @default.
• W2739459975 hasConcept C96232424 @default.
• W2739459975 hasConceptScore W2739459975C121608353 @default.
• W2739459975 hasConceptScore W2739459975C126322002 @default.
• W2739459975 hasConceptScore W2739459975C143998085 @default.
• W2739459975 hasConceptScore W2739459975C1491633281 @default.
• W2739459975 hasConceptScore W2739459975C195687474 @default.
• W2739459975 hasConceptScore W2739459975C203014093 @default.
• W2739459975 hasConceptScore W2739459975C502942594 @default.
• W2739459975 hasConceptScore W2739459975C530470458 @default.
• W2739459975 hasConceptScore W2739459975C54355233 @default.
• W2739459975 hasConceptScore W2739459975C71924100 @default.
• W2739459975 hasConceptScore W2739459975C81885089 @default.
• W2739459975 hasConceptScore W2739459975C85789140 @default.
• W2739459975 hasConceptScore W2739459975C86803240 @default.
• W2739459975 hasConceptScore W2739459975C96232424 @default.
• W2739459975 hasLocation W27394599751 @default.
• W2739459975 hasOpenAccess W2739459975 @default.
• W2739459975 hasPrimaryLocation W27394599751 @default.
• W2739459975 hasRelatedWork W2081167504 @default.
• W2739459975 hasRelatedWork W2162820194 @default.
• W2739459975 hasRelatedWork W2364309381 @default.
• W2739459975 hasRelatedWork W2372715335 @default.
• W2739459975 hasRelatedWork W2381427931 @default.
• W2739459975 hasRelatedWork W2383356758 @default.
• W2739459975 hasRelatedWork W2387611812 @default.
• W2739459975 hasRelatedWork W2392572192 @default.
• W2739459975 hasRelatedWork W2419359705 @default.
• W2739459975 hasRelatedWork W2804583635 @default.
• W2739459975 hasRelatedWork W2887442514 @default.
• W2739459975 hasRelatedWork W2901110077 @default.
• W2739459975 hasRelatedWork W2902820475 @default.
• W2739459975 hasRelatedWork W2974066226 @default.
• W2739459975 hasRelatedWork W2981694965 @default.
• W2739459975 hasRelatedWork W3013147361 @default.
• W2739459975 hasRelatedWork W3028793528 @default.
• W2739459975 hasRelatedWork W3029036909 @default.
• W2739459975 hasRelatedWork W3113910931 @default.
• W2739459975 hasRelatedWork W2336830714 @default.
• W2739459975 hasVolume "13" @default.
• W2739459975 isParatext "false" @default.
• W2739459975 isRetracted "false" @default.
• W2739459975 magId "2739459975" @default.
• W2739459975 workType "article" @default.